Navidea Biopharmaceuticals Inc EV/EBIT
What is the EV/EBIT of Navidea Biopharmaceuticals Inc?
The EV/EBIT of Navidea Biopharmaceuticals Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with ev/ebit similar to Navidea Biopharmaceuticals Inc
- Azelio AB (publ) has EV/EBIT of N/A
- AutoWeb Inc has EV/EBIT of N/A
- Palatin Technologies has EV/EBIT of N/A
- 9 Meters Biopharma has EV/EBIT of N/A
- Codrus Minerals has EV/EBIT of N/A
- Cerence Inc has EV/EBIT of N/A
- Navidea Biopharmaceuticals Inc has EV/EBIT of N/A
- PAVmed Inc has EV/EBIT of N/A
- Synairgen plc has EV/EBIT of N/A
- Akoustis Technologies Inc has EV/EBIT of N/A
- Vaxart Inc has EV/EBIT of N/A
- Blue Thunder Mining has EV/EBIT of N/A
- Radha Madhav has EV/EBIT of N/A